ReviewJournal of hematology & oncology2017
Syk inhibitors in clinical development for hematological malignancies.
Delong Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
101 papers cite itlatest 60 shown
this paperpooled itcites it